|
|
|
|
Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study
|
|
|
|
|
|
|
|
نویسنده
|
lachmann h. ,cattalini m. ,obici l. ,barcellona r. ,speziale a. ,joubert y. ,junge g. ,gattorno m.
|
|
منبع
|
pediatric rheumatology - 2015 - دوره : 13 - شماره : 1
|
|
چکیده
|
[no abstract available]
|
|
|
|
|
آدرس
|
university college london,london, United Kingdom, university of brescia,pediatric clinic,brescia, Italy, policlinico s. matteo,pavia, Italy, hospital sciacca,sciacca, Italy, novartis pharma ag,basel, Switzerland, novartis pharma ag,basel, Switzerland, novartis pharma ag,basel, Switzerland, g gaslini institute,genova, Italy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|